We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Onyx Scientific Clinches Cancer Research UK Contract

Onyx Scientific Clinches Cancer Research UK Contract

Onyx Scientific Clinches Cancer Research UK Contract

Onyx Scientific Clinches Cancer Research UK Contract

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Onyx Scientific Clinches Cancer Research UK Contract"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The team at Cancer Research UK initially approached its preferred suppliers with its requirements and a proposed development route. After analyzing the charity’s needs in more detail, the technical team at Onyx Scientific has improved the synthetic methodology as well as suggesting an alternative route, which long term will potentially help make the project more efficient and cost effective.

Dr Nigel Westwood, drug supply manager at Cancer Research UK, said: “Having had a very positive experience of using Onyx Scientific’s process development and GMP manufacturing services in the past, they seemed like a strong candidate for this important project.

“Despite the fact that Cancer Research UK had to change suppliers at such a critical stage, Onyx Scientific still expect to bring the project in on time and on budget. Given their expertise in chemistry and ability to deliver, we believe they are perfect fit for the project,” added Dr Westwood.

Onyx Scientific provides outsourced facilities and expertise to help pharmaceutical and biotech companies accelerate drug candidates from discovery, through development, into Phase I/II GMP API manufacturing. The Cancer Research UK project is one of the biggest projects in the firm’s history and is expected to take around seven months to complete.

Denise Bowser, commercial director at Onyx Scientific, said: “We are delighted to be working again with the team at Cancer Research UK on this major project as it clearly indicates confidence in our technical expertise, customer service and ability to deliver on time.

“The input we have had to date has been positive and has no doubt demonstrated our commitment to go the extra mile for clients by meeting their requirements as efficiently as possible.”